NO20080024L - Sammensetninger og metoder for behandling av syklus-relaterte symptomer - Google Patents
Sammensetninger og metoder for behandling av syklus-relaterte symptomerInfo
- Publication number
- NO20080024L NO20080024L NO20080024A NO20080024A NO20080024L NO 20080024 L NO20080024 L NO 20080024L NO 20080024 A NO20080024 A NO 20080024A NO 20080024 A NO20080024 A NO 20080024A NO 20080024 L NO20080024 L NO 20080024L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- compositions
- related symptoms
- treating cycle
- cycle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Metoder er gitt for behandling av syklusrelaterte symptomer ved administrering av minst ett progestin og minst ett østrogen til et kvinnelig individ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69507705P | 2005-06-28 | 2005-06-28 | |
PCT/US2006/025449 WO2007002862A2 (en) | 2005-06-28 | 2006-06-27 | Compositions and methods for treatment of cycle-related symptoms |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080024L true NO20080024L (no) | 2008-03-27 |
Family
ID=37440889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080024A NO20080024L (no) | 2005-06-28 | 2008-01-03 | Sammensetninger og metoder for behandling av syklus-relaterte symptomer |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070009594A1 (no) |
EP (1) | EP1896037A2 (no) |
JP (1) | JP2008544989A (no) |
KR (1) | KR20080017061A (no) |
CN (1) | CN101252937A (no) |
AR (1) | AR054525A1 (no) |
AU (1) | AU2006263542A1 (no) |
BR (1) | BRPI0613021A2 (no) |
CA (1) | CA2612885A1 (no) |
CR (1) | CR9601A (no) |
EC (1) | ECSP078066A (no) |
GT (1) | GT200600280A (no) |
IL (1) | IL188237A0 (no) |
MX (1) | MX2007016364A (no) |
NO (1) | NO20080024L (no) |
PE (1) | PE20070327A1 (no) |
RU (1) | RU2007148080A (no) |
TW (1) | TW200726473A (no) |
WO (1) | WO2007002862A2 (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
DE102007011486A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Arzneimittel umfassend wenigstens ein Gestagen |
US20120263784A1 (en) * | 2009-10-12 | 2012-10-18 | Lyka Labs Limited | Emergency contraceptive |
UY33103A (es) * | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
WO2012129812A1 (zh) * | 2011-03-31 | 2012-10-04 | 深圳市康泰尔电子有限公司 | 电子香烟 |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
DE102019115343A1 (de) * | 2019-06-06 | 2020-12-10 | EVESTRA GmbH | Vaginalring für die hormonelle Kontrazeption |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
JPS60174716A (ja) * | 1984-02-21 | 1985-09-09 | Yamanouchi Pharmaceut Co Ltd | パツチ剤 |
US4752478A (en) * | 1984-12-17 | 1988-06-21 | Merck & Co., Inc. | Transdermal system for timolol |
DE19705229C2 (de) * | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
EP2305229A1 (en) * | 2001-12-05 | 2011-04-06 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
EP1648382A4 (en) * | 2003-07-16 | 2009-09-16 | Duramed Pharmaceuticals Inc | HORMONE TREATMENT METHODS USING CONTRACEPTIVE DOSAGES WITH CONTINUOUS ADMINISTRATION OF ESTROGENES |
WO2005117898A1 (en) * | 2004-05-26 | 2005-12-15 | Wyeth | Compositions and methods for treatment of premenstrual dysphoric disorder |
-
2006
- 2006-06-21 TW TW095122320A patent/TW200726473A/zh unknown
- 2006-06-26 US US11/475,486 patent/US20070009594A1/en not_active Abandoned
- 2006-06-27 CN CNA2006800316370A patent/CN101252937A/zh active Pending
- 2006-06-27 KR KR1020077030684A patent/KR20080017061A/ko not_active Application Discontinuation
- 2006-06-27 WO PCT/US2006/025449 patent/WO2007002862A2/en active Application Filing
- 2006-06-27 EP EP06774301A patent/EP1896037A2/en not_active Withdrawn
- 2006-06-27 BR BRPI0613021-6A patent/BRPI0613021A2/pt not_active Application Discontinuation
- 2006-06-27 AU AU2006263542A patent/AU2006263542A1/en not_active Abandoned
- 2006-06-27 JP JP2008519582A patent/JP2008544989A/ja active Pending
- 2006-06-27 MX MX2007016364A patent/MX2007016364A/es not_active Application Discontinuation
- 2006-06-27 CA CA002612885A patent/CA2612885A1/en not_active Abandoned
- 2006-06-27 RU RU2007148080/14A patent/RU2007148080A/ru not_active Application Discontinuation
- 2006-06-28 GT GT200600280A patent/GT200600280A/es unknown
- 2006-06-28 AR ARP060102786A patent/AR054525A1/es not_active Application Discontinuation
- 2006-06-28 PE PE2006000760A patent/PE20070327A1/es not_active Application Discontinuation
-
2007
- 2007-12-18 CR CR9601A patent/CR9601A/es not_active Application Discontinuation
- 2007-12-19 IL IL188237A patent/IL188237A0/en unknown
- 2007-12-28 EC EC2007008066A patent/ECSP078066A/es unknown
-
2008
- 2008-01-03 NO NO20080024A patent/NO20080024L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL188237A0 (en) | 2008-06-05 |
ECSP078066A (es) | 2008-01-23 |
KR20080017061A (ko) | 2008-02-25 |
PE20070327A1 (es) | 2007-05-04 |
RU2007148080A (ru) | 2009-08-10 |
AU2006263542A1 (en) | 2007-01-04 |
CA2612885A1 (en) | 2007-01-04 |
EP1896037A2 (en) | 2008-03-12 |
MX2007016364A (es) | 2008-03-05 |
BRPI0613021A2 (pt) | 2010-12-14 |
TW200726473A (en) | 2007-07-16 |
JP2008544989A (ja) | 2008-12-11 |
WO2007002862A2 (en) | 2007-01-04 |
CN101252937A (zh) | 2008-08-27 |
CR9601A (es) | 2008-05-05 |
US20070009594A1 (en) | 2007-01-11 |
AR054525A1 (es) | 2007-06-27 |
WO2007002862A3 (en) | 2007-02-22 |
GT200600280A (es) | 2007-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080024L (no) | Sammensetninger og metoder for behandling av syklus-relaterte symptomer | |
UA100250C2 (uk) | Інгібітори реплікації вірусу імунодефіциту людини | |
UA92355C2 (en) | urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS | |
DK1836169T3 (da) | Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser | |
DK2023918T3 (da) | Cyclosporiner til behandlingen og forebyggelse af okulære lidelser | |
NZ594746A (en) | Inhibitors of iap | |
SG157365A1 (en) | Compositions and methods for treating neoplastic diseases | |
EA200870385A1 (ru) | Ингибирование токсичности альфа-синуклеина | |
TW200716606A (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
DK1893196T3 (da) | Diarylhydantoin-forbindelse | |
DE602007010664D1 (de) | P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen | |
NO20091576L (no) | Sammensetninger av TRL-ligander og antiviraler | |
TW200738657A (en) | Thiazole compounds and methods of use | |
GEP20125565B (en) | Lactam compounds and their pharmaceutical use | |
WO2010059004A3 (ko) | 스네일-p53 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제 | |
MX2009013353A (es) | Compuestos activadores de telomerasa y metodos para su uso. | |
MX2012007032A (es) | Composiciones organicas para tratar las enfermedades relacionadas con hsf1. | |
BRPI0720050A2 (pt) | 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas | |
TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
EP2077719A4 (en) | BETA-SECRETASE PIPERIDINE AND PYRROLIDINE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
DK1814879T3 (da) | Derivater af 4,7-dioxobenzothiazol-2-caboxamider, fremgangsmåde til fremstilling deraf og terapeutiske anvendelser af samme | |
WO2008002614A3 (en) | Pseudoazulenyl nitrones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |